<DOC>
	<DOCNO>NCT00324792</DOCNO>
	<brief_summary>The primary objective study assess effect 3-month intensive insulin therapy urinary leukotriene E4 ( LTE4 ) excretion patient diabetes .</brief_summary>
	<brief_title>I3LTE4 : Intensive Insulin Therapy Production LTE4 Patients With Diabetes</brief_title>
	<detailed_description>Our group recently report result preliminary cross-sectional study , demonstrate urinary LTE4 excretion increase patient type 1 diabetes . With regard recent human genetic study show polymorphisms 5-lipoxygenase ( 5-LO ) promoter FLAP haplotypes link cardiovascular disease susceptibility data suggest potential interest LTE4 non-invasive biomarker cardiovascular risk . In diabetes mellitus , study require evaluate 5-LO pathway improvement glucose control concomitantly establish inflammatory cardiovascular biomarkers . The secondary objective : Before 3-month intensive insulin therapy- Relationship marker platelet activation ( urinary 11-dehydro-thromboxan B2 :11-dehydroTXB2 ) urinary LTE4- Relationship inflammatory plasma marker cardiovascular risk ( hs-CRP fibrinogen ) urinary LTE4- Relationship plasma marker endothelial dysfunction ( sICAM-1 ) urinary LTE4- Changes LTE4 accord patient subgroup ( patient type 1 type 2 diabetes mellitus )</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>diabetes mellitus ( type 1 type 2 ) &gt; 18 yearold subject give free , informed write consent subject entitle health insurance cover medical followup department Diabetology , Grenoble University Hospital inappropriate glucose control ( HbA1c &gt; 8.5 % ) require initiation , revision , insulin therapy legal incapacity limited legal competence pregnant woman heart failure impair renal function , define creatinin clearance &lt; 60 ml/mn accord Cockroft formula asthma respiratory failure IV , IM , SC oral treatment corticosteroid last 2 month prior baseline current smoking &gt; cigarette / day infectious disease last 2 month prior baseline baseline CRP &gt; 20 mg/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>